China Reform Health Management and Services Group Co Ltd

The company's capital structure is characterized by a debt-to-equity ratio of 0.57, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 2.03, suggesting the company has sufficient short-term assets to cover its short-term liabilities. However, the company reported negative operating cash flow of -81.66 million CNY and free cash flow of -411.91 million CNY, signaling potential liquidity constraints. Profitability metrics reveal a challenging financial position. The company reported a net loss of 403.99 million CNY and an operating loss of 403.91 million CNY. Return on equity is -40.08%, and return on assets is -22.45%, both significantly below industry norms. Gross profit of 74.33 million CNY on revenue of 350.44 million CNY indicates a gross margin of approximately 21.21%, which is relatively low for the health care services sector. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to sector-specific risks and limits the ability to offset losses in one area with gains in another. Growth trajectory is negative, with the company reporting a significant decline in profitability. The operating loss and net loss suggest a deteriorating financial performance. Historical revenue data does not indicate a clear upward trend, and the outlook for the current and next fiscal years remains uncertain. Risk factors include a high level of debt, with long-term debt of 574.82 million CNY, and negative net cash flow, which could lead to liquidity constraints. The company's dilution potential is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. However, the negative operating and free cash flows may necessitate future financing, potentially leading to dilution. Recent events, as disclosed in the latest financial filings, highlight the company's financial challenges, including significant operating and net losses. No recent transcripts or major events have been disclosed that would indicate a turnaround or strategic shift.